Combination of finasteride and flutamide as potency-sparing hormone ablation therapy in management of advanced carcinoma of prostate

Combination of finasteride and flutamide as potency-sparing hormone ablation therapy in management of advanced carcinoma of prostate

Complete androgen blockade by LHRH agonist /Orchiectomy plus antiandrogen results in androgen deficiency amongst males (ADAM). We treated advanced cancer prostate with finasteride and flutamide with an aim of potency sparing in relatively younger males with the disease. 45 sexually active males betw...

Full description

Bibliographic Details
Main Authors: N K Mohanty, R P Arora, A K Jha, Sujeet Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2001-01-01
Series:Indian Journal of Urology
Subjects:
α-Reductase Inhibitor
Potency: Hormone: Flutamide; Finasteride.
Online Access:http://www.indianjurol.com/article.asp?issn=0970-1591;year=2001;volume=18;issue=1;spage=49;epage=51;aulast=Mohanty

Internet

http://www.indianjurol.com/article.asp?issn=0970-1591;year=2001;volume=18;issue=1;spage=49;epage=51;aulast=Mohanty

Similar Items